Interviews


Prof. Poulsen Discusses Targeted Protein Degradation & Native Mass Spec
Dr. Sally Ann Poulsen explains how native mass spectrometry can be used to better understand and develop degrader-based therapeutics, one of the newest modalities in drug development. Her analysis of E3 ligase-involved ternary complexes in collaboration with Alessio Ciulli's laboratory is featured at Drug Discovery Chemistry Europe on the Lead Generation Strategies track in Barcelona 10-12, November 2026. .


Register
Lead Generation Strategies
Next-Gen Degraders & Molecular Glues